Latest Vioxx Stories
After nearly 13 years of study and intense debate, a pair of new papers from the Perelman School of Medicine, at the University of Pennsylvania have confirmed exactly how a once-popular class of anti-inflammatory drugs leads to cardiovascular risk for people taking it.
Drugmaker Merck & Co will pay $950 million to settle criminal and civil charges that it marketed its Vioxx for an unapproved use, the U.S. Justice Department said on Tuesday.
Falls and fractures among senior citizens have increased since rofecoxib (Vioxx®) was removed from the market in 2004, according to research presented this week at the American College of
New research shows that medications which have raised safety concerns over heart attack and stroke risks may not have gotten approval from the Food and Drug Administration (FDA) if the cardiovascular effects of fluid retention had been better understood.
A research team from the University of California, Davis and Peking University, China, has discovered a novel mechanism as to why the long-term, high-dosage use of the well-known arthritis pain medication, Vioxx, led to heart attacks and strokes.
Provides lessons for post-market pharmaceutical safety.
Researchers said on Monday that a long-term analysis of people who took the arthritis drug Vioxx confirms it doubles the risk of strokes and heart attacks, but this risk goes away a year after people stop taking it.
By Brezis, Mayer Belmaker, R H Mayer Brezis, MD, MPH Center for Clinical Quality & Safety, Hadassah Medical Center & School of Public Health, The Hebrew University of Jerusalem, Israel Abstract: A landmark paper on Game Theory showed that individual maximization of profit necessarily endangers the public good, and since the problem has no technical solution, "it requires a fundamental extension in morality" (1).
The primary purpose of a 1999 clinical study that Merck & Co Inc said was done to test side effects of Vioxx, was actually to support a marketing campaign before the now-withdrawn painkiller's launch, according to U.S. researchers.
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.